trial · primary record
SND002 Cell Injection
Colorectal Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 78 |
| Primary completion | 2030-02-28 |
| Primary endpoint | Number of participants with treatment-emergent adverse events, serious adverse events, and dose-limiting toxicities |
| Registry ID | NCT07903857 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:05.239Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07903857
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.